Ads
related to: Fasenra- Eosinophil Diseases
Learn About A Treatment For
Multiple Eosinophil-Driven Diseases
- Adverse Reaction Info
Explore Safety Information For
A Severe Asthma Treatment.
- Prescribing Information
Get Prescribing Information For A
Severe Eosinophilic Asthma Therapy.
- Clinical Trial Data
View Clinical Trial Data For A
Severe Eosinophilic Asthma Med.
- Eosinophil Diseases
Search results
AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation
Benzinga via Yahoo Finance· 1 year agoAstraZeneca Plc (NASDAQ: AZN) has reported topline data from the MESSINA Phase 3 trial Fasenra...
Pennsylvania woman stunned to be charged $50K for asthma medication. No one can explain it
USA TODAY via Yahoo News· 1 year agoYORK, Pa. — Jessica Eckard has always had asthma problems. Her father died of tuberculosis when she...
AstraZeneca drug fails one main goal in study of chronic immune disease
Reuters via Yahoo News· 1 year agoThe condition, eosinophilic esophagitis, is characterised by inflammation and damage to the...
AstraZeneca (AZN) Posts Upbeat Data on Lung Cancer Drug Combo
Zacks via Yahoo Finance· 7 months agoData from a late-stage study shows that AstraZeneca's (AZN) Tagrisso combined with chemotherapy cut...
Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More
Zacks via Yahoo Finance· 6 months agoThe FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo...
Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod
Zacks via Yahoo Finance· 1 year agoThis week, Novartis NVS and Merck MRK announced their third-quarter earnings. The FDA approved J&J’s...
AstraZeneca (AZN) Key Drugs to Aid Growth, Pipeline Strong
Zacks via Yahoo Finance· 6 months agoAstraZeneca's (AZN) key drugs like Lynparza, Tagrisso, Fasenra and Farxiga should keep driving...
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN fourth-quarter 2022 core earnings of 69 cents per American depositary share (ADS)...
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
Zacks via Yahoo Finance· 5 months agoAstraZeneca’s AZN third-quarter 2023 core earnings of 87 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
Zacks via Yahoo Finance· 11 months agoAstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...
Ads
related to: Fasenra